Search

for
Search:

Research

5 / 1000+ results

research Microbioreactor design for eukaryotic cell-based biomedical applications

July 2026 in “Frontiers in Bioengineering and Biotechnology”

Microbioreactors improve cell-based therapies and personalized medicine but face scalability challenges.

research Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

March 2026 in “MedComm”

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

research Detection of lentiviral constructs for release testing of CAR- T cells using digital droplet PCR

1 citations , May 2019 in “Cytotherapy”

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

research Exploiting Unique Features of Microneedles to Modulate Immunity

39 citations , June 2023 in “Advanced Materials”

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

research Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes

2 citations , January 2026 in “Frontiers in Endocrinology”

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

View more "t-cell manufacturing" in research →

Community Join

5 / 1000+ results

community HairClone developing cell replacement treatments for Hair Loss

7 upvotes 7 years ago

HairClone is developing cell replacement treatments to rejuvenate and generate hair follicles, and has launched a crowdfunding campaign. A user expressed skepticism about the need for crowdfunding.

community HairClone: Good info from their site

in Technology 10 upvotes 4 years ago

HairClone aims to rejuvenate miniaturizing hair follicles through follicle banking and cell expansion, with treatments potentially available in the UK by 2022. The process involves extracting, storing, and cloning hair follicles, but full regenerative treatments will take many years to develop.

community Quote from Pelage (PP-405) Spokesperson...

in Research/Science 122 upvotes 9 months ago

Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

community My summation of PP405 - looks promising

in Research/Science 206 upvotes 1 year ago

PP405 shows promise for hair regrowth by manipulating stem cell characteristics and lactate dehydrogenase, with Phase 2a trials pending. Google Ventures' $15M investment suggests confidence, but results and market availability remain uncertain.

community A warning to anyone considering 3rd party sourcing PP405 or its analogs

in Treatment 31 upvotes 4 months ago

Be cautious when sourcing PP405 or its analogs from third-party suppliers due to potential safety risks and lack of regulatory approval. The conversation highlights concerns about counterfeit products and the absence of reliable testing, making it risky to use such treatments.

View more "t-cell manufacturing" in community →